Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific ... Read More

Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More

Boston Scientific expands Farapulse’s reach in afib with new FDA approval

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use into patients with persistent atrial fibrillation lasting at least seven ... Read More

Newer pulsed field ablation ‘already as effective’ as radiofrequency ablation

Pulsed field ablation demonstrated similarly durable atrial fibrillation ablation as radiofrequency ablation, with fewer procedure-related adverse events and shorter procedure time, researchers ... Read More

Boston Scientific Presses Its Advantage in Pulsed Field Ablation

Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a prolonged ... Read More

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

Increases in procedural speed and safety, however, support the continuing shift to the newer modality, one expert says. Read More

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) ... Read More